Protagenic Therapeutics, Inc.
(NASDAQ: PTIX)

Performance Technologies, Incorporated (PT) is a global supplier of advanced network communications solutions to service providers, government and other equipment manufacturer (OEM) markets. PT's product portfolio includes Internet protocol (IP)-centric network elements and applications designed for availability, scalability, and long life cycle deployments. PT solutions include Monterey 8000 MicroTCA and IPnexus Platforms. PT's SEGway Signaling Solutions provide signaling, advanced routing for IP migration, gateway capabilities, session initiation protocol (SIP) bridging, and distributed intelligence, as well as features, such as Number Portability. Its Xpress NGN applications enable Mobile 2.0, Multi-media, and IMS-based revenue-generating services. Its products include SEGway Signaling Solutions and Monterey and IPnexus Application-Ready Platforms, and Xpress SIP Applications. In February 2014, Sonus Networks Inc completed the acquisition of Performance Technologies Inc (PT).

2.830 s

+0.010 (+0.35%)
Range 2.720 - 2.939   (8.05%)
Open 2.720
Previous Close 2.820
Bid Price 2.080
Bid Volume 8
Ask Price 2.150
Ask Volume 14
Volume 39,118
Value -
Remark s
Delayed prices. Updated at 09 Aug 2025 04:00.
Data powered by
View All Events

About Protagenic Therapeutics

Performance Technologies, Incorporated (PT) is a global supplier of advanced network communications solutions to service providers, government and other equipment manufacturer (OEM) markets. PT's product portfolio includes Internet protocol (IP)-centric network elements and applications designed f...
more

Top Contributors

USNews avatar
347
Followers 277
Posts 1283231
Share your investing ideas
Please login to view stock data and analysis